News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Iran seized the Chinese-owned security vessel Hui Chuan near the Strait of Hormuz after requesting documentation and escorting it into Iranian waters.
  • The U.S. and Israel are preparing coordinated military operations against Iran, including air strikes and attacks on oil infrastructure, potentially starting next week.
  • President Trump threatened to withdraw support for Rep. Lauren Boebert after she campaigned for Rep. Thomas Massie.
  • Robinhood is shifting revenue toward deposit-led net interest income and prediction markets, pitching a tactical long trade based on rising NII.
  • Two campaign workers for Colombian right-wing candidate Abelardo De La Espriella were killed in Meta province ahead of the May 31 election.

Latest Articles

Equitable Holdings CEO Sells $1.8M in Stock Ahead of Notable Revenue Miss

Equitable Holdings CEO Sells $1.8M in Stock Ahead of Notable Revenue Miss

Equitable Holdings President and CEO Mark Pearson sold 39,700 shares on February 18, 2026, for about $1.8 million while also exercising options to acquire 27,200 shares at $23.18. The stock is trading below recent highs and InvestingPro flags the equity as appearing overvalued. Separately, Equitable reported Q4 2025 EPS in line with expectations bu…

FDA Clears All-Oral Calquence and Venetoclax Regimen for CLL and SLL

FDA Clears All-Oral Calquence and Venetoclax Regimen for CLL and SLL

The U.S. Food and Drug Administration has approved AstraZeneca’s Calquence (acalabrutinib) in combination with venetoclax as the first all-oral, fixed-duration regimen for adults with chronic lymphocytic leukaemia (CLL) and small lymphocytic lymphoma (SLL). The decision is grounded in results from the AMPLIFY Phase III trial, which demonstrated hig…

Gentex VP Disposes Nearly $500k in Stock While Retaining Substantial Stake

Gentex VP Disposes Nearly $500k in Stock While Retaining Substantial Stake

Gentex Vice President of Sales Matthew Chiodo sold 19,827 shares on February 17, 2026, for about $496,170, while also recording zero-price acquisitions and tax-related share withholdings in filings with the SEC. The transactions leave Chiodo with 47,148 shares. Separately, Gentex posted a slight EPS beat but a marginal revenue shortfall for Q4 2025…

Tokyo stocks retreat as Nikkei 225 falls 1.07% at Friday close

Tokyo stocks retreat as Nikkei 225 falls 1.07% at Friday close

Tokyo’s Nikkei 225 slipped 1.07% at Friday’s close as losses concentrated in Paper & Pulp, Transport and Communication stocks outpaced gains. Mitsui Mining and Smelting, IHI Corp. and Sumitomo Electric Industries were among the session’s top advancers, while Sumitomo Dainippon Pharma, Olympus and Seven & i Holdings recorded the day’s steepest decli…

Robinhood CFO Disposes $411k in Stock; Holds 51,771 Shares After Sale

Robinhood CFO Disposes $411k in Stock; Holds 51,771 Shares After Sale

Robinhood Markets Inc CFO Shiv Verma sold 5,474 shares of Class A common stock on February 17, 2026, collecting roughly $411,273 in proceeds. The trades, carried out at prices between $73.444 and $76.3638, left Verma with direct ownership of 51,771 shares. The transaction occurred under a Rule 10b5-1 trading plan adopted in August 2025 amid a perio…

Commerce.com Executive Chair Purchases $294,080 in Series 1 Shares

Commerce.com Executive Chair Purchases $294,080 in Series 1 Shares

Commerce.com Executive Chair Ellen F. Siminoff bought 100,000 shares of the company’s Series 1 Common Stock on February 17, 2026, paying between $2.905 and $2.99 per share for a total of $294,080. The purchase comes while the stock trades near its 52-week low and follows recent corporate integrations with Stripe and analyst downgrades and price-tar…

MACOM CFO Disposes $1.75M in Stock as Company Posts Strong Q1 Results

MACOM CFO Disposes $1.75M in Stock as Company Posts Strong Q1 Results

John Kober, MACOM Technology Solutions' Senior VP and CFO, sold 7,039 shares on February 17, 2026 under a pre-arranged Rule 10b5-1 trading plan, generating roughly $1.75 million. The transaction occurred as the shares traded near a 52-week high, while the company reported first-quarter fiscal 2026 revenue and adjusted EPS that beat guidance and ana…

HubSpot Director Disposes $2.09M in Shares Amid Heavy One-Year Decline

HubSpot Director Disposes $2.09M in Shares Amid Heavy One-Year Decline

HubSpot Inc. director Brian Halligan sold 8,261 shares on February 17, 2026, for $253.00 per share, a transaction totaling $2.09 million, according to a Form 4 filing with the Securities and Exchange Commission. The sale was carried out under a 10b5-1 trading plan adopted March 3, 2025, and was signed by attorney-in-fact Joseph Theis on February 19…